Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 408

    Alembic Pharma gets tentative USFDA nod for erectile dysfunction drug

    Alembic Pharma gets tentative USFDA nod for erectile dysfunction drug

    Ruby Khatun Khatun5 July 2017 12:46 PM IST
    New Delhi: Alembic Pharmaceuticals has received tentative approval from the US health regulator for vardenafil hydrochloride tablets used for...
    Glenmark Pharma gets UK drug regulator nod for OTC sale of anti-malarial drug

    Glenmark Pharma gets UK drug regulator nod for OTC sale of anti-malarial drug

    Ruby Khatun Khatun5 July 2017 12:46 PM IST
    New Delhi: Glenmark Pharma on Tuesday said the UK drug regulator MHRA has granted final approval to Glenmark Pharmaceuticals Europe for anti-malarial...
    Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

    Sun Pharma ,Samsung BioLogics announce 55.5 million dollar tie-up for psoriasis drug Tildrakizumab

    Ruby Khatun Khatun5 July 2017 12:40 PM IST
    Mumbai: Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by...
    Zydus Cadila anti-diabetic drug gets USFDA marketing nod

    Zydus Cadila anti-diabetic drug gets USFDA marketing nod

    Ruby Khatun Khatun5 July 2017 12:39 PM IST
    New Delhi: Drug firm Zydus Cadila on Tuesday said it has received tentative approval from the US health regulator to market anti diabetic sitagliptin...
    CDSCO approves marketing of Russian biosimilar of rituximab in India

    CDSCO approves marketing of Russian biosimilar of rituximab in India

    Ruby Khatun Khatun5 July 2017 12:38 PM IST
    SAINT PETERSBURG: On 20th of June 2017, the Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab...
    Expect lower Q1 sales in India due to GST implementation: DRL

    Expect lower Q1 sales in India due to GST implementation: DRL

    Ruby Khatun Khatun4 July 2017 1:10 PM IST
    New Delhi: Drug major Dr Reddy's Laboratories (DRL) expects the first quarter of the ongoing fiscal to witness a temporary decline in sales in India...
    Indian pharma sector growth to moderate in next 3 yrs: ICRA

    Indian pharma sector growth to moderate in next 3 yrs: ICRA

    Ruby Khatun Khatun4 July 2017 1:09 PM IST
    New Delhi: Indian pharmaceutical industry is likely to witness moderation in growth in the next three years mainly due to decline in revenues from the...
    Strides Shasun gets USFDA go-ahead for anti-allergy drug

    Strides Shasun gets USFDA go-ahead for anti-allergy drug

    Ruby Khatun Khatun4 July 2017 11:33 AM IST
    New Delhi: Strides Shasun said it has received approval from the US health regulator for promethazine hydrochloride tablets used to treat allergy...
    Wockhardt gets USFDA nod for generic eye drops

    Wockhardt gets USFDA nod for generic eye drops

    Ruby Khatun Khatun4 July 2017 11:13 AM IST
    New Delhi: Drug firm Wockhardt has received approval from the US health regulator for generic Olopatadine HCl eye drops used for the treatment of...
    License of 34 medical stores cancelled in Bijnor

    License of 34 medical stores cancelled in Bijnor

    Ruby Khatun Khatun4 July 2017 9:01 AM IST
    Bijnor: After a raid was conducted by a team of officials on medical stores in different parts of Bijnor district, the drug administration has...
    GST to benefit common man: Shripad Naik

    GST to benefit common man: Shripad Naik

    Ruby Khatun Khatun3 July 2017 2:27 PM IST
    Panaji: Union Minister for AYUSH, Shripad Naik said apart from streamlining the tax regime in the country, the Goods and Services Tax (GST) will...
    Big pharma turns to artificial intelligence to speed drug discovery, GSK signs deal

    Big pharma turns to artificial intelligence to speed drug discovery, GSK signs deal

    Ruby Khatun Khatun3 July 2017 12:34 PM IST
    London: The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok